Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Renalytix plc - Sponsored ADR (RNLXD : OTC)

• Company Description    Renalytix plc is an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and advance value-based care. Renalytix plc, formerly known as RENALYTIX AI, is based in NEW YORK. Number of Employees: 46

• Price / Volume Information    Yesterday's Closing Price: $3.88 Daily Weekly Monthly 20 Day Moving Average: 3,848 shares Shares Outstanding: 8.74 (millions) Market Capitalization: $33.91 (millions) Beta: 2.66 52 Week High: $8.09 52 Week Low: $3.13 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 7.03% 5.79% 12 Week -39.71% -41.57% Year To Date -26.13% -37.31%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 2 Leman Street - London,X0 E1W 9US GBR ph: 44-20-3139-2910 fax: - investors@renalytix.com http://www.renalytix.com

• General Corporate Information    Officers James McCullough - Chief Executive Officer and Director Julian Baines - Executive Chairman Howard Doran - President Joel R. Jung - Chief Financial Officer Catherine Coste - Director Peer Information Renalytix plc - Sponsored ADR (HLIS) Renalytix plc - Sponsored ADR (AZTA) Renalytix plc - Sponsored ADR (APYI) Renalytix plc - Sponsored ADR (RNVA) Renalytix plc - Sponsored ADR (HMSY) Renalytix plc - Sponsored ADR (LRSI) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MEDICAL INFO SYS Sector: Medical CUSIP: 75973T200 SIC: 8071 Fiscal Year Fiscal Year End: June Last Reported Quarter: 09/01/24 Next Expected EPS Date: 12/30/25 Share - Related Items Shares Outstanding: 8.74 Most Recent Split Date: 12.00 (0.04:1) Beta: 2.66 Market Capitalization: $33.91 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 12/30/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: - Price / Sales: 14.42 EPS Growth vs. Year Ago Period: 63.64% vs. Previous Quarter: 0.00% Sales Growth vs. Year Ago Period: 13.73% vs. Previous Quarter: -10.92% ROE 09/30/25 - - 06/30/25 - - 03/31/25 - - ROA 09/30/25 - - 06/30/25 - - 03/31/25 - - Current Ratio 09/30/25 - - 06/30/25 - 1.21 03/31/25 - - Quick Ratio 09/30/25 - - 06/30/25 - 1.17 03/31/25 - - Operating Margin 09/30/25 - - 06/30/25 - - 03/31/25 - - Net Margin 09/30/25 - - 06/30/25 - - 03/31/25 - - Pre-Tax Margin 09/30/25 - - 06/30/25 - -726.67 03/31/25 - - Book Value 09/30/25 - - 06/30/25 - -1.06 03/31/25 - - Inventory Turnover 09/30/25 - - 06/30/25 - 8.75 03/31/25 - - Debt-to-Equity 09/30/25 - - 06/30/25 - - 03/31/25 - - Debt-to-Capital 09/30/25 - - 06/30/25 - - 03/31/25 - -

Powered by Zacks Investment Research ©